Brightside Health

Brightside Health is a leading national telehealth platform that delivers virtual, measurement-based mental healthcare for individuals dealing with mild to severe clinical conditions. Operating as a comprehensive system of action for behavioral health, Brightside provides specialized treatment plans across all 50 states for anxiety, depression, insomnia, postpartum distress, obsessive-compulsive disorder (OCD), and bipolar II. Rather than focusing solely on mild mental wellness, Brightside is built to manage higher-acuity cases, offering specialized services that include dedicated individual therapy, psychiatric medication management, a nationwide Teen Program, and a clinical Suicide Prevention Program.

When medication is deemed clinically necessary, Brightside psychiatric providers utilize a proprietary, data-driven AI matching tool called PrecisionRx. Instead of relying on a traditional trial-and-error approach to prescribing antidepressants or sleep aids, the PrecisionRx algorithm analyzes more than 100 distinct personal data points from a patient's clinical assessment against thousands of potential medication combinations. This precision model predicts which non-controlled clinical treatments (such as SSRIs or SNRIs) are statistically most likely to be well-tolerated and effective for the individual's specific biology. This algorithmic grounding helps over 70% of members respond positively to their very first prescription.

Brightside Health maintains a strict, non-negotiable policy prohibiting its psychiatric providers from prescribing medications classified as federal controlled substances, regardless of a patient's historical clinical diagnoses. This means that the platform cannot prescribe stimulant medications for ADHD (such as Adderall, Vyvanse, Concerta, or Ritalin) nor can it prescribe benzodiazepines for acute panic and severe anxiety (such as Xanax, Klonopin, Ativan, or Valium). Instead, Brightside providers manage conditions using non-controlled, non-addictive medical alternatives, treating ADHD exclusively through non-stimulant therapies and managing anxiety via targeted daily maintenance medications.

Yes, Brightside features a specialized Teen Program designed explicitly for adolescents aged 13 to 17. Recognizing that youth mental health requires unique operational boundaries, the program provides evidence-based, therapy-first care delivered by licensed clinicians who are specifically trained in adolescent psychology and crisis prevention. The platform employs a dual-portal interface that preserves a teenager's therapeutic autonomy and privacy while keeping parents informed and involved. Additionally, Brightside clinicians evaluate the impact of digital habits and social media on the teen's emotional well-being, integrating specialized digital habit assessments directly into the treatment pipeline.